Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Aug 31, 2015 2:22pm
187 Views
Post# 24065767

RE:Response to PoC regarding post-hoc analysis/MACE RRR, ARR

RE:Response to PoC regarding post-hoc analysis/MACE RRR, ARRBDAZ, thank you for another brillant ind insightful post!

Thank heavens we have you to try to keep prince honest but there is no hope for that, although, every once in a while he provides some little nuggets to think about...and then correct.

(sorry Toniv if the % sign isn’t supposed to be there) - This funny. Good one. The % sign should be there followed by the word "point" in the ARR calculation. So in a population with a specific definition such as DM with CVD and low HDL you could multiply that % point number by the actual population to determine the number of people who did not have a MACE as a result of rvx-208.

I truly appreciate you keeping prince in line. While I do not have a problem with anyone being critical of RVX I prefer to see the criticism in a logical and accurate discourse as opposed to some crazy hyperbole put forward by poc. But, the world is made up of all types and the Internet is sort of democratic so let the game play on.

I almost wonder if poc has brilliantly targeted some sort of niche of readers (conspiracy theory type wierdos) that would find his/her/its post of appeal...almost like reality shows or something???

Anyway, I don't like to post like this. It is a waste of my time. I prefer the scientific objectivity. We all know that replication is required and we know the DM with CVD and low HDL population is huge. We all know that medicines are selective.

Anyway BDAZ thanks for your tremendous efforts to bring understanding and objectivity.
Cheers
Toinv


Bullboard Posts